NEW YORK (GenomeWeb News) – Affymetrix has confirmed that the unnamed company that it said last week that it had acquired is True Materials, a microparticle technology firm based in the University of California, San Francisco, Mission Bay Campus.
 
An Affymetrix spokesperson told GenomeWeb Daily News via e-mail that True Materials founder Randy True has joined Affy as a vice president of research and development.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.